Keyword Analysis & Research: harrow health


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
harrow health0.230.336325213
harrow0.860.88324886
health1.110.7732446

Keyword Research: People who searched harrow health also searched

Keyword CPC PCC Volume Score
harrow health1.590.7780394

Search Results related to harrow health on Search Engine

  • Harrow

    harrow.com

    https://www.harrow.com/

    WebWe make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions.

    DA: 86 PA: 56 MOZ Rank: 55

  • Harrow Health Acquires Patented Ophthalmic Surgical Drug …

    harrow.com

    https://investors.harrow.com/news-releases/news-release-details/harrow-health-acquires-patented-ophthalmic-surgical-drug

    WebNASHVILLE, Tenn. & MENDRISIO, Switzerland -- (BUSINESS WIRE)--Jul. 27, 2021-- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced that it has entered into an agreement with Sintetica, S.A., a growing pharmaceutical company focused on analgesics, local anesthetics and sterile injectable solutions, to ...

    DA: 18 PA: 48 MOZ Rank: 90

  • Harrow Health Launches New Corporate and Investor Website - Yahoo Finance

    yahoo.com

    https://finance.yahoo.com/news/harrow-health-launches-corporate-investor-130000900.html

    WebJun 1, 2021 · Harrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare company. The Company owns ImprimisRx, the nation’s leading ophthalmology outsourcing and pharmaceutical compounding...

    DA: 77 PA: 44 MOZ Rank: 42

  • Harrow Health - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Harrow_Health

    WebHarrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company (Nasdaq: HROW) based in Nashville, TN. Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company.

    DA: 74 PA: 73 MOZ Rank: 29

  • Harrow Health Acquires Rights To Novartis' Five Approved …

    yahoo.com

    https://finance.yahoo.com/news/harrow-health-acquires-rights-novartis-144117947.html

    WebDec 14, 2022 · Harrow Health Acquires Rights To Novartis' Five Approved Ophthalmic Products. Vandana Singh. Wed, Dec 14, 2022 1 min read. In this article: NOVN.SW. HROW. NVS. Harrow Health Inc (NASDAQ:...

    DA: 85 PA: 23 MOZ Rank: 98


  • Harrow Health Announces Fourth Quarter and Year-End 2021 …

    harrow.com

    https://investors.harrow.com/news-releases/news-release-details/harrow-health-announces-fourth-quarter-and-year-end-2021

    WebHarrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare company. The Company owns and operates ImprimisRx, one of the nation’s leading ophthalmology-focused pharmaceutical businesses, and Visionology, a direct-to-consumer eye care subsidiary focused on chronic vision care.

    DA: 76 PA: 15 MOZ Rank: 57

  • Harrow Health Announces First Quarter 2022 Financial Results | Harrow…

    harrow.com

    https://investors.harrow.com/news-releases/news-release-details/harrow-health-announces-first-quarter-2022-financial-results

    WebMay 5, 2022 at 4:01 PM EDT. Seventh Consecutive Quarter of Record Results. Highlights for First Quarter 2022: Record revenues of $22.1 million, up 43% over $15.4 million for the prior-year quarter. Record gross profit of $16.2 million, …

    DA: 87 PA: 64 MOZ Rank: 67

  • Harrow Health, Inc. (HROW) Stock Price, Quote & News - Stock …

    stockanalysis.com

    https://stockanalysis.com/stocks/hrow/

    Web5 days ago · The Compan... 4 weeks ago - Business Wire. Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024.

    DA: 15 PA: 66 MOZ Rank: 12

  • Harrow Health Announces Second Quarter 2022 Financial Results | Harrow …

    harrow.com

    https://investors.harrow.com/news-releases/news-release-details/harrow-health-announces-second-quarter-2022-financial-results

    WebAug 9, 2022 · Highlights for Second Quarter 2022: Record revenues of $23.3 million, up 29% over $18.1 million for the prior‑year quarter. Record gross profit of $16.8 million, up 22% over $13.7 million for the prior‑year quarter. A record 718,000 product units shipped, up 4% from the sequential first quarter of 2022.

    DA: 30 PA: 48 MOZ Rank: 83

  • Investor FAQs | Harrow, Inc. - Harrow Health, Inc

    harrow.com

    https://investors.harrow.com/ir-resources/investor-faqs

    WebA trust company, bank or similar financial institution assigned by a corporation to maintain records of investors and account balances and transactions, to cancel and issue certificates, to process investor mailings and to deal with any …

    DA: 82 PA: 67 MOZ Rank: 85